Literature DB >> 14973037

Differential impact of MexB mutations on substrate selectivity of the MexAB-OprM multidrug efflux pump of Pseudomonas aeruginosa.

Jocelyn K Middlemiss1, Keith Poole.   

Abstract

The integral inner membrane resistance-nodulation-division (RND) components of three-component RND-membrane fusion protein-outer membrane factor multidrug efflux systems define the substrate selectivity of these efflux systems. To gain a better understanding of what regions of these proteins are important for substrate recognition, a plasmid-borne mexB gene encoding the RND component of the MexAB-OprM multidrug efflux system of Pseudomonas aeruginosa was mutagenized in vitro by using hydroxylamine and mutations compromising the MexB contribution to antibiotic resistance identified in a DeltamexB strain. Of 100 mutants that expressed wild-type levels of MexB and showed increased susceptibility to one or more of carbenicillin, chloramphenicol, nalidixic acid, and novobiocin, the mexB genes of a representative 46 were sequenced, and 19 unique single mutations were identified. While the majority of mutations occurred within the large periplasmic loops between transmembrane segment 1 (TMS-1) and TMS-2 and between TMS-7 and TMS-8 of MexB, mutations were seen in the TMSs and in other periplasmic as well as cytoplasmic loops. By threading the MexB amino acid sequence through the crystal structure of the homologous RND transporter from Escherichia coli, AcrB, a three-dimensional model of a MexB trimer was obtained and the mutations were mapped to it. Unexpectedly, most mutations mapped to regions of MexB predicted to be involved in trimerization or interaction with MexA rather than to regions expected to contribute to substrate recognition. Intragenic second-site suppressor mutations that restored the activity of the G220S mutant version of MexB, which was compromised for resistance to all tested MexAB-OprM antimicrobial substrates, were recovered and mapped to the apparently distal portion of MexB that is implicated in OprM interaction. As the G220S mutation likely impacted trimerization, it appears that either proper assembly of the MexB trimer is necessary for OprM interaction or OprM association with an unstable MexB trimer might stabilize it, thereby restoring activity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14973037      PMCID: PMC344428          DOI: 10.1128/JB.186.5.1258-1269.2004

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  65 in total

1.  Influence of mutations in the mexR repressor gene on expression of the MexA-MexB-oprM multidrug efflux system of Pseudomonas aeruginosa.

Authors:  R Srikumar; C J Paul; K Poole
Journal:  J Bacteriol       Date:  2000-03       Impact factor: 3.490

2.  On the mechanism of substrate specificity by resistance nodulation division (RND)-type multidrug resistance pumps: the large periplasmic loops of MexD from Pseudomonas aeruginosa are involved in substrate recognition.

Authors:  Weimin Mao; Mark S Warren; Deborah S Black; Takahumi Satou; Takeshi Murata; Takeshi Nishino; Naomasa Gotoh; Olga Lomovskaya
Journal:  Mol Microbiol       Date:  2002-11       Impact factor: 3.501

3.  The substrate specificity of tripartite efflux systems of Pseudomonas aeruginosa is determined by the RND component.

Authors:  Takeshi Murata; Misato Kuwagaki; Tomoko Shin; Naomasa Gotoh; Takeshi Nishino
Journal:  Biochem Biophys Res Commun       Date:  2002-11-29       Impact factor: 3.575

4.  Identification of putative active-site residues in the DNase domain of colicin E9 by random mutagenesis.

Authors:  C Garinot-Schneider; A J Pommer; G R Moore; C Kleanthous; R James
Journal:  J Mol Biol       Date:  1996-08-02       Impact factor: 5.469

5.  Molecular mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.

Authors:  S Jalal; O Ciofu; N Hoiby; N Gotoh; B Wretlind
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

6.  Involvement of an active efflux system in the natural resistance of Pseudomonas aeruginosa to aminoglycosides.

Authors:  J R Aires; T Köhler; H Nikaido; P Plésiat
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

7.  Characterization of a Pseudomonas aeruginosa efflux pump contributing to aminoglycoside impermeability.

Authors:  S Westbrock-Wadman; D R Sherman; M J Hickey; S N Coulter; Y Q Zhu; P Warrener; L Y Nguyen; R M Shawar; K R Folger; C K Stover
Journal:  Antimicrob Agents Chemother       Date:  1999-12       Impact factor: 5.191

8.  Chimeric analysis of the multicomponent multidrug efflux transporters from gram-negative bacteria.

Authors:  Elena B Tikhonova; Quiju Wang; Helen I Zgurskaya
Journal:  J Bacteriol       Date:  2002-12       Impact factor: 3.490

9.  Substrate specificity of the RND-type multidrug efflux pumps AcrB and AcrD of Escherichia coli is determined predominantly by two large periplasmic loops.

Authors:  Christopher A Elkins; Hiroshi Nikaido
Journal:  J Bacteriol       Date:  2002-12       Impact factor: 3.490

10.  The secondary multidrug transporter LmrP contains multiple drug interaction sites.

Authors:  M Putman; L A Koole; H W van Veen; W N Konings
Journal:  Biochemistry       Date:  1999-10-19       Impact factor: 3.162

View more
  41 in total

1.  Reversal of the Drug Binding Pocket Defects of the AcrB Multidrug Efflux Pump Protein of Escherichia coli.

Authors:  Ketaki Soparkar; Alfred D Kinana; Jon W Weeks; Keith D Morrison; Hiroshi Nikaido; Rajeev Misra
Journal:  J Bacteriol       Date:  2015-08-03       Impact factor: 3.490

Review 2.  Vacuuming the periplasm.

Authors:  Olga Lomovskaya; Maxim Totrov
Journal:  J Bacteriol       Date:  2005-03       Impact factor: 3.490

3.  Interaction of the MexA and MexB components of the MexAB-OprM multidrug efflux system of Pseudomonas aeruginosa: identification of MexA extragenic suppressors of a T578I mutation in MexB.

Authors:  Dominic Nehme; Keith Poole
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

4.  Mutations in the central cavity and periplasmic domain affect efflux activity of the resistance-nodulation-division pump EmhB from Pseudomonas fluorescens cLP6a.

Authors:  Elizabeth M Hearn; Murray R Gray; Julia M Foght
Journal:  J Bacteriol       Date:  2006-01       Impact factor: 3.490

5.  Fitting periplasmic membrane fusion proteins to inner membrane transporters: mutations that enable Escherichia coli AcrA to function with Pseudomonas aeruginosa MexB.

Authors:  Ganesh Krishnamoorthy; Elena B Tikhonova; Helen I Zgurskaya
Journal:  J Bacteriol       Date:  2007-11-16       Impact factor: 3.490

6.  Site-directed mutagenesis reveals amino acid residues in the Escherichia coli RND efflux pump AcrB that confer macrolide resistance.

Authors:  Caroline Wehmeier; Sabine Schuster; Eva Fähnrich; Winfried V Kern; Jürgen A Bohnert
Journal:  Antimicrob Agents Chemother       Date:  2008-10-20       Impact factor: 5.191

Review 7.  Efflux-mediated drug resistance in bacteria: an update.

Authors:  Xian-Zhi Li; Hiroshi Nikaido
Journal:  Drugs       Date:  2009-08-20       Impact factor: 9.546

8.  Optimization of meropenem minimum concentration/MIC ratio to suppress in vitro resistance of Pseudomonas aeruginosa.

Authors:  Vincent H Tam; Amy N Schilling; Shadi Neshat; Keith Poole; David A Melnick; Elizabeth A Coyle
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

9.  β-Lactam selectivity of multidrug transporters AcrB and AcrD resides in the proximal binding pocket.

Authors:  Naoki Kobayashi; Norihisa Tamura; Hendrik W van Veen; Akihito Yamaguchi; Satoshi Murakami
Journal:  J Biol Chem       Date:  2014-02-20       Impact factor: 5.157

10.  Prevalence, resistance mechanisms, and susceptibility of multidrug-resistant bloodstream isolates of Pseudomonas aeruginosa.

Authors:  Vincent H Tam; Kai-Tai Chang; Kamilia Abdelraouf; Cristina G Brioso; Magdalene Ameka; Laurie A McCaskey; Jaye S Weston; Juan-Pablo Caeiro; Kevin W Garey
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.